414-1 (Active Motif/Fudan University)

N/A

Report date: 2025/01/26 18:43:57

Base Information

Drug Name414-1 (Active Motif/Fudan University)
Drug Alias Nameanti-SARS-CoV-2 antibodies (Active Motif/Fudan University/Hisun BioRay)virus-neutralizing antibodies (Active Motif/Fudan University/Hisun BioRay)anti-SARS-CoV-2 spike protein antibody (Active Motif/Fudan University)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionCoronavirus spike glycoprotein inhibitors
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesActive Motif Inc
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang BioRay Biopharmaceuticals Co Ltd
Inactive CompaniesActive Motif IncFudan University
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A